The DOI matches its Crossref record; 242 of the 242 references it cites were found in a registry or an index.
Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms
Open accessAbstract
Due to the complexity of multifactorial diseases, single-target drugs do not always exhibit satisfactory efficacy. Recently, increasing evidence indicates that simultaneous modulation of multiple targets may improve both therapeutic safety and efficacy, compared with single-target drugs. However, few multitarget drugs are on market or in clinical trials, despite the best efforts of medicinal chemists. This article discusses the systematic establishment of target combination, lead generation, and optimization of multitarget-directed ligands (MTDLs). Moreover, we analyze some MTDLs research cases for several complex diseases in recent years and the physicochemical properties of 117 clinical multitarget drugs, with the aim to reveal the trends and insights of the potential use of MTDLs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–242 of 242
Toda, N., Kaneko, T., & Kogen, H. (2010) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.58.273 · Cited by 42
Wang, Z., & Vince, R. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.01.025 · Cited by 42
Detecting similar binding pockets to enable systems polypharmacology
Duran‐Frigola, M., Siragusa, L., Ruppin, E., Barril, X., Cruciani, G., & Aloy, P. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005522 · Cited by 42
Vermeulen, E. S., Schmidt, A. W., Sprouse, J. S., Wikström, H., & Grol, C. J. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030826m · Cited by 41
Leveraging Large-scale Behavioral Profiling in Zebrafish to Explore Neuroactive Polypharmacology
McCarroll, M. N., Gendelev, L., Keiser, M. J., & Kokel, D. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b00800 · Cited by 41
Advances in rationally designed dual inhibitors of HIV-1 reverse transcriptase and integrase
Gu, S., Xue, P., Ju, X.-L., & Zhu, Y. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.09.025 · Cited by 41
Gu, Z., Zhou, A., Xiao, Y., Zhang, Q., & Li, J. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.12.063 · Cited by 41
de Vries, P. J., Bích, N. N., Thien, H. V., Hung, L. N., Anh, T. K., Kager, P. A., & Heisterkamp, S. H. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.5.1302-1308.2000 · Cited by 40
Hybrid Dual Aromatase-Steroid Sulfatase Inhibitors with Exquisite Picomolar Inhibitory Activity
Woo, L. W. L., Bubert, C., Purohit, A., & Potter, B. V. L. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100273k · Cited by 39
Tang, Z., Wu, C.-Z., Wang, T., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.04.029 · Cited by 38
Geerts, H., Roberts, P., & Spiros, Ä. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00198 · Cited by 37
Affinity Reagents that Target a Specific Inactive Form of Protein Kinases
Ranjitkar, P., Brock, A. M., & Maly, D. J. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.01.008 · Cited by 37
Gains in employment status following antidepressant medication or cognitive therapy for depression
Fournier, J. C., DeRubeis, R. J., Amsterdam, J., Shelton, R. C., & Hollon, S. D. (2015) · British Journal of Psychiatry · doi:10.1192/bjp.bp.113.133694 · Cited by 36
Lötsch, J., & Geißlinger, G. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.10.003 · Cited by 36
New drugs in psychiatry: focus on new pharmacological targets
Caraci, F., Leggio, G. M., Salomone, S., & Drago, F. (2017) · F1000Research · doi:10.12688/f1000research.10233.1 · Cited by 36
Tang, Z., Niu, S., Liu, F., Lao, K., Miao, J., Ji, J., Wang, X., Yan, M., Zhang, L., You, Q., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.03.042 · Cited by 35
Multitarget Molecular Hybrids of Cinnamic Acids
Peperidou, A., Καπουκρανίδου, Δ., Kontogiorgis, C. A., & Hadjipavlou‐Litina, D. (2014) · Molecules · doi:10.3390/molecules191220197 · Cited by 33
Identification and validation of bioactive small molecule target through phenotypic screening
Cho, Y. S., & Kwon, H. J. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.11.021 · Cited by 33
Quantitative phosphoproteomic analysis of acquired cancer drug resistance to pazopanib and dasatinib
Vyse, S., McCarthy, F., Broncel, M., Paul, A., Wong, J. P.-M., Bhamra, A., & Huang, P. H. (2017) · Journal of Proteomics · doi:10.1016/j.jprot.2017.08.015 · Cited by 33
Woo, L. W. L., Wood, P. M., Bubert, C., THOMAS, M. P., Purohit, A., & Potter, B. V. L. (2013) · ChemMedChem · doi:10.1002/cmdc.201300015 · Cited by 32
Studies on reduction of S-nitrosoglutathione by human carbonyl reductases 1 and 3
Staab-Weijnitz, C. A., Hartmanová, T., El-Hawari, Y., Ebert, B., Kisiela, M., Wsól, V., Martin, H.-J., & Maser, E. (2011) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2011.01.016 · Cited by 30
Gangjee, A., Zhao, Y., Raghavan, S., Rohena, C. C., Mooberry, S. L., & Hamel, E. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400639z · Cited by 28
Brunschweiger, A., Koch, P., Schlenk, M., Pineda, F., Küppers, P., Hinz, S., Köse, M., Ullrich, S., Hockemeyer, J., Wiese, M., et al. (2014) · ChemMedChem · doi:10.1002/cmdc.201402082 · Cited by 27
Jia, J., Cui, M., Dai, J., & Liu, B. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00209 · Cited by 26
Treating mixed mania/hypomania: a review and synthesis of the evidence
Takeshima, M. (2016) · CNS Spectrums · doi:10.1017/s1092852916000845 · Cited by 26
Chua, H. E., Bhowmick, S. S., & Tucker‐Kellogg, L. (2017) · Methods · doi:10.1016/j.ymeth.2017.05.015 · Cited by 26
Designed multiple ligands in metabolic disease research: from concept to platform
Gattrell, W. T., Johnstone, C., Patel, S., Smith, C. S., Scheel, A. A., & Schindler, M. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.02.006 · Cited by 25
Brunschweiger, A., Koch, P., Schlenk, M., Rafehi, M., Radjainia, H., Küppers, P., Hinz, S., Pineda, F., Wiese, M., Hockemeyer, J., et al. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.09.003 · Cited by 23
New perspectives: role of Sunitinib in breast cancer.
Fratto, M. E., Imperatori, M., Vincenzi, B., Tomao, F., Santini, D., & Tonini, G. (2010) · PubMed · Cited by 21
Gangjee, A., Zhao, Y., Hamel, E., Westbrook, C., & Mooberry, S. L. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2007722 · Cited by 21
Approaches towards the development of chimeric DPP4/ACE inhibitors for treating metabolic syndrome
Sattigeri, J. A., Sethi, S., Davis, J. A., Ahmed, S., Rayasam, G., Jadhav, B. G., Chilla, S. N. M., Datta, D., Gadhave, A., Tulasi, V. K., et al. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.04.036 · Cited by 20
A Computational Approach to the Study of the Binding Mode of Dual ACE/NEP Inhibitors
Dimitropoulos, N., Papakyriakou, A., Dalkas, G. A., Sturrock, E. D., & Spyroulias, G. A. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci9005047 · Cited by 17
The importance of predictive biomarkers in oncology drug development
Jørgensen, J. T. (2016) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2016.1199962 · Cited by 15
Design, synthesis and biological evaluation of 1,3-diphenylbenzo[f][1,7]naphthyrdines
Arepalli, S. K., Park, B., Lee, K., Jo, H., Jun, K.-Y., Kwon, Y., Kang, J. S., Jung, J., & Lee, H. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.08.030 · Cited by 15
Bisi, A., Gobbi, S., Belluti, F., & Rampa, A. (2013) · Current Medicinal Chemistry · doi:10.2174/0929867311320130012 · Cited by 14
SAMITAL ® : A New Botanical Drug for the Treatment of Mucositis Induced by Oncological Therapies
Morazzoni, P., Petrangolini, G., Bombardelli, E., Ronchi, M., Cabri, W., & Riva, A. (2013) · Future Oncology · doi:10.2217/fon.13.165 · Cited by 13
Synthesis and Dual Histamine H1 and H2 Receptor Antagonist Activity of Cyanoguanidine Derivatives
Sadek, B. S., Alisch, R. A., Buschauer, A., & Elz, S. (2013) · Molecules · doi:10.3390/molecules181114186 · Cited by 13
Fujita, M., Seki, T., Inada, H., Shimizu, K., Takahama, A., & Sano, T. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00731-4 · Cited by 13
Blixt, F. W., Haanes, K. A., Ohlsson, L., Christiansen, A. T., Warfvinge, K., & Edvinsson, L. I. (2018) · Acta Ophthalmologica · doi:10.1111/aos.13651 · Cited by 12
Medicinal Chemistry Approaches for Multitarget Drugs
Morphy, R., & Ranković, Z. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc124 · Cited by 8
Chemoinformatics Profiling of the Chromone Nucleus as a MAO-B/A2AAR Dual Binding Scaffold
Cruz‐Monteagudo, M., Borges, F., Cordeiro, M. N. D. S., Helguera, A. M., Tejera, E., Paz‐y‐Miño, C., Sánchez‐Rodríguez, A., Perera-Sardiña, Y., & Pérez‐Castillo, Y. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170116145316 · Cited by 6
Kolb (2001) · doi:10.1002/1521-3773(20010601)40:11<2004::aid-anie2004>3.0.co;2-5
Cited by
Albertini, C., Salerno, A., de Sena Murteira Pinheiro, P., & Bolognesi, M. L. (2021) · Medicinal Research Reviews · doi:10.1002/med.21699 · Cited by 179
Li, Y., Sang, S., Ren, W., Pei, Y., Bian, Y., Chen, Y., & Sun, H. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113874 · Cited by 77
Self-citationHe, F., Chou, C. J., Scheiner, M., Poeta, E., Yuan Chen, N., Gunesch, S., Hoffmann, M., Sotriffer, C., Monti, B., Maurice, T., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01940 · Cited by 66
Jiang, X., Zhou, J., Wang, Y., Chen, L., Duan, Y., Huang, J., Liu, C., Chen, Y., Liu, W., Sun, H., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112751 · Cited by 39
Self-citation(2022) · PubMed Central · Cited by 17
Metadata
- Authors
- Zhou, J., Jiang, X., He, S., Jiang, H., Feng, F., Liu, W., Qu, W., & Sun, H.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2019-05-13
- Volume
- 62
- Issue
- 20
- Pages
- 8881-8914
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2945427404
- Cited by
- 281
- References
- 242
- FWCI
- 19.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.